Suppr超能文献

指南综述:英国胃肠病学会/英国原发性硬化性胆管炎诊断与管理指南

Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.

作者信息

Nicoletti Alberto, Maurice James B, Thorburn Douglas

机构信息

Sheila Sherlock Liver Centre and UCL Institute for Liver and Digestive Health, Royal Free London NHS Foundation Trust, London, UK.

Internal Medicine, Gastroenterology and Hepatology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Frontline Gastroenterol. 2020 Mar 2;12(1):62-66. doi: 10.1136/flgastro-2019-101343. eCollection 2021.

Abstract

New British Society of Gastroenterology/UK-PSC guidelines have recently discussed the current state-of-the-art on primary sclerosing cholangitis and outlined key elements for the management of this disease. The current lack of effective pharmacological treatments to prevent progression of liver fibrosis to cirrhosis limits our ability to modify the natural history of the disease. However, a personalised approach and structured follow-up could allow earlier diagnosis and management of complications and favour access to liver transplantation, which remains the only available treatment. Our commentary overviews the updates and summarises the key recommendations of the recent guidelines for the management of primary sclerosing cholangitis.

摘要

英国胃肠病学会/英国原发性硬化性胆管炎指南最近讨论了原发性硬化性胆管炎的当前技术水平,并概述了该疾病管理的关键要素。目前缺乏有效的药物治疗来预防肝纤维化进展为肝硬化,这限制了我们改变该疾病自然病程的能力。然而,个性化方法和结构化随访可以实现并发症的早期诊断和管理,并有助于获得肝移植,而肝移植仍然是唯一可用的治疗方法。我们的评论概述了这些更新内容,并总结了最近原发性硬化性胆管炎管理指南的关键建议。

相似文献

1
Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
Frontline Gastroenterol. 2020 Mar 2;12(1):62-66. doi: 10.1136/flgastro-2019-101343. eCollection 2021.
3
Guideline review: British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis treatment and management guidelines.
Frontline Gastroenterol. 2019 Jul;10(3):316-319. doi: 10.1136/flgastro-2018-101109. Epub 2019 Jan 9.
4
Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
J Hepatol. 2019 Oct;71(4):773-782. doi: 10.1016/j.jhep.2019.05.023. Epub 2019 Jun 5.
5
Endoscopic Management of Primary Sclerosing Cholangitis.
Ann Hepatol. 2017;16(6):842-850. doi: 10.5604/01.3001.0010.5274.
6
Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Eur J Med Genet. 2021 Jun;64(6):104231. doi: 10.1016/j.ejmg.2021.104231. Epub 2021 Apr 24.
7
Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
Radiographics. 2019 Nov-Dec;39(7):1938-1964. doi: 10.1148/rg.2019180213. Epub 2019 Oct 18.
8
Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.
United European Gastroenterol J. 2016 Aug;4(4):562-9. doi: 10.1177/2050640615616012. Epub 2015 Oct 30.
9
The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):603-609. doi: 10.1097/MPG.0000000000001368.

引用本文的文献

2
Previously Untreated Ulcerative Colitis With Newly Diagnosed Primary Sclerosing Cholangitis: A Case Report.
Cureus. 2023 Sep 15;15(9):e45311. doi: 10.7759/cureus.45311. eCollection 2023 Sep.
4
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders.
Antibiotics (Basel). 2023 Jun 17;12(6):1068. doi: 10.3390/antibiotics12061068.
5
Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
World J Gastroenterol. 2022 Nov 28;28(44):6213-6229. doi: 10.3748/wjg.v28.i44.6213.
6
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome.
J Gastrointest Oncol. 2022 Oct;13(5):2532-2538. doi: 10.21037/jgo-22-165.
7
Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis.
Front Immunol. 2022 Aug 17;13:912961. doi: 10.3389/fimmu.2022.912961. eCollection 2022.
8
ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
Can J Gastroenterol Hepatol. 2022 Jul 21;2022:2372257. doi: 10.1155/2022/2372257. eCollection 2022.
9
Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study.
Diagnostics (Basel). 2022 Mar 12;12(3):697. doi: 10.3390/diagnostics12030697.
10
Is it time for recommendations to reflect reality in PSC surveillance?
Frontline Gastroenterol. 2021 Mar 23;13(1):88-89. doi: 10.1136/flgastro-2021-101812. eCollection 2022.

本文引用的文献

1
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2416-2422. doi: 10.1016/j.cgh.2019.07.011. Epub 2019 Jul 12.
4
Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review.
Semin Liver Dis. 2019 Feb;39(1):104-110. doi: 10.1055/s-0038-1676099. Epub 2018 Nov 22.
5
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.
6
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
Gastroenterology. 2016 Oct;151(4):660-669.e4. doi: 10.1053/j.gastro.2016.06.021. Epub 2016 Jun 21.
7
A review of the medical treatment of primary sclerosing cholangitis in the 21st century.
Ther Adv Chronic Dis. 2016 Jan;7(1):68-85. doi: 10.1177/2040622315605821.
9
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
J Hepatol. 2015 Nov;63(5):1139-46. doi: 10.1016/j.jhep.2015.07.005. Epub 2015 Jul 14.
10
Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience.
Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1051-8. doi: 10.1097/MEG.0b013e3283554bbf.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验